Skip to content

GRCE

Grace Therapeutics, Inc.

NASDAQ · Healthcare · Biotechnology · US

$2.11
−0.94%
Ask drillr
4
Insider buys (3m)
0
Insider sells (3m)
$270.1K
Net value (3m)
-5.8%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Sep 10, 2026Opaleye Management Inc. · 10 percent ownerPurchase9,393$2.10
Sep 10, 2026Kohli Prashant · director, officer: Chief Executive OfficerPurchase100,000$2.14
Sep 10, 2026Opaleye Management Inc. · 10 percent ownerPurchase5,836$2.09
Sep 1, 2026DelAversano Robert J · officer: Principal Financial OfficerA-Award33,660$2.12
Sep 1, 2026Kohli Prashant · director, officer: Chief Executive OfficerA-Award267,160$2.12
Sep 1, 2026Kumar Amresh · officer: VP Program ManagementA-Award35,760$2.12
Sep 1, 2026Macdonald R. Loch · officer: Chief Medical OfficerA-Award54,690$2.12
Aug 19, 2026Opaleye Management Inc. · 10 percent ownerPurchase11,608$2.09
Jan 12, 2026Kavuru Vimal · directorA-Award10,000$3.80
Jan 12, 2026Kottayil George · directorA-Award10,000$3.80
Jan 12, 2026NEUGEBOREN EDWARD · directorA-Award10,000$3.80
Jan 12, 2026DAVIS A BRIAN · directorA-Award10,000$3.80
May 13, 2025Kavuru Vimal · directorA-Award10,000$2.72
May 13, 2025DAVIS A BRIAN · directorA-Award10,000$2.72
May 13, 2025NEUGEBOREN EDWARD · directorA-Award10,000$2.72
May 13, 2025Kottayil George · directorA-Award10,000$2.72
Apr 16, 2025D'Andrea Carrie · officer: VP Clinical OperationsA-Award30,000$2.08
Apr 16, 2025Kumar Amresh · officer: VP Program ManagementA-Award30,000$2.08
Apr 16, 2025Kohli Prashant · director, officer: Chief Executive OfficerA-Award225,400$2.08
Apr 16, 2025DelAversano Robert J · officer: Principal Financial OfficerA-Award20,130$2.08
Apr 16, 2025Macdonald R. Loch · officer: Chief Medical OfficerA-Award40,000$2.08
Institutional positioning

13F filings over the trailing two quarters

New 28Increased 18Reduced 9Sold out 11
FilerActionSharesFiled
CERITY PARTNERS LLCIncreased849,055May 15, 2026
Cerity Partners LLCUnchanged849,055Aug 14, 2026
Eversept Partners, LPIncreased772,900Aug 14, 2026
EVERSEPT PARTNERS, LPNew Position756,600May 15, 2026
NANTAHALA CAPITAL MANAGEMENT, LLCReduced728,203May 15, 2026
BANK OF AMERICA CORP /DE/Increased494,723May 18, 2026
BANK OF AMERICA CORP /DE/Reduced494,698Aug 14, 2026
VANGUARD CAPITAL MANAGEMENT LLCIncreased411,714Aug 13, 2026
CITADEL ADVISORS LLCIncreased402,240Sep 2, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position401,656May 15, 2026
RENAISSANCE TECHNOLOGIES LLCIncreased243,910May 14, 2026
Maven Securities LTDNew Position200,000Aug 14, 2026
JANE STREET GROUP, LLCNew Position167,097May 12, 2026
JANE STREET GROUP, LLCReduced161,542Aug 14, 2026
Birchview Capital, LPIncreased120,000Aug 14, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Sep 10, 2026